Previous studies have also demonstrated that c-MET is a prognostic factor for colon cancer, however, Stein et al showed that the combination of MACC1 and c-MET expression did not improve the prognosis for five-year survival or metastasis, indicating that MACC1 may serve as an independent prognostic factor. Here, MET is linked to malignant colon neoplasm.